Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gabriel

Showing results (301-310 of 459) with videos related to

Pageof 46
Sort By:
JACC. Cardiovascular Interventions|January 23, 2016
Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting StentsJames B Hermiller, Mitchell W Krucoff, Dean J Kereiakes, et al.
European Heart Journal|November 21, 2015
Causes of late mortality with dual antiplatelet therapy after coronary stentsLaura Mauri, Sammy Elmariah, Robert W Yeh, et al.
Circulation|August 1, 2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialP Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
JAMA Cardiology|March 16, 2017
Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) StudyEric A Secemsky, Robert W Yeh, Dean J Kereiakes, et al.
European Heart Journal|April 13, 2006
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trialPadma Kaul, Wei-Ching Chang, A Michael Lincoff, et al.
Circulation|May 14, 2014
Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial"P Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 9, 2021
Patient Perspectives on the Risk-Based NLST Outcomes Tool for Lung Cancer ScreeningMegan C Roberts, Elizabeth L Seaman, William M P Klein, et al.
European Journal of Preventive Cardiology|May 17, 2014
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO TrialManesh R Patel, Richard C Becker, Daniel M Wojdyla, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Stroke|October 28, 2006
Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registryEmmanuel Touzé, Jean-Louis Mas, Joachim Röther, et al.
Pageof 46

Showing results (301-310 of 459) with videos related to

Sort By:
Pageof 46
JACC. Cardiovascular Interventions|January 23, 2016
Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting StentsJames B Hermiller, Mitchell W Krucoff, Dean J Kereiakes, et al.
European Heart Journal|November 21, 2015
Causes of late mortality with dual antiplatelet therapy after coronary stentsLaura Mauri, Sammy Elmariah, Robert W Yeh, et al.
Circulation|August 1, 2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trialP Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
JAMA Cardiology|March 16, 2017
Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) StudyEric A Secemsky, Robert W Yeh, Dean J Kereiakes, et al.
European Heart Journal|April 13, 2006
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trialPadma Kaul, Wei-Ching Chang, A Michael Lincoff, et al.
Circulation|May 14, 2014
Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial"P Gabriel Steg, Robert A Harrington, Håkan Emanuelsson, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 9, 2021
Patient Perspectives on the Risk-Based NLST Outcomes Tool for Lung Cancer ScreeningMegan C Roberts, Elizabeth L Seaman, William M P Klein, et al.
European Journal of Preventive Cardiology|May 17, 2014
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO TrialManesh R Patel, Richard C Becker, Daniel M Wojdyla, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Stroke|October 28, 2006
Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registryEmmanuel Touzé, Jean-Louis Mas, Joachim Röther, et al.
Pageof 46